Home/Filings/4/0001181431-05-036952
4//SEC Filing

RENOVIS INC 4

Accession 0001181431-05-036952

CIK 0001118361operating

Filed

Jun 26, 8:00 PM ET

Accepted

Jun 27, 8:04 PM ET

Size

8.0 KB

Accession

0001181431-05-036952

Insider Transaction Report

Form 4
Period: 2005-06-24
KELLY MICHAEL GERALD
VP, Drug Discovery
Transactions
  • Sale

    Common Stock

    2005-06-24$15.00/sh3,000$45,00054,800 total
Footnotes (2)
  • [F1]Disposition of securities made pursuant to a 10b5-1 plan.
  • [F2]Includes 2,225 shares purchased through the Company's Employee Stock Purchase Plan.

Issuer

RENOVIS INC

CIK 0001118361

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001118361

Filing Metadata

Form type
4
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 8:04 PM ET
Size
8.0 KB